153 related articles for article (PubMed ID: 3238157)
1. [Efficacy of follow-up in colorectal cancer: second look guided by carcinoembryonic antigen (CEA) and secondary neoplasms].
Marcuello Gaspar E; Manuel Nogueras F; Sánchez Parra M; Gajo Reyero R; Germá Lluch JR; Salvador Navarro R; Garriga Viayna J
Rev Esp Enferm Apar Dig; 1988 Nov; 74(5):535-9. PubMed ID: 3238157
[No Abstract] [Full Text] [Related]
2. [CEA (carcinoembryonic antigen): its value as an early indicator of recurrence of neoplastic disease in carcinoma of the colon and rectum].
Lacatena M; Comes P; Argese AV; Colucci G
Minerva Chir; 1989 Jun; 44(11):1597-9. PubMed ID: 2771111
[TBL] [Abstract][Full Text] [Related]
3. Postsurgical surveillance for recurrence of UICC stage I colorectal carcinoma: is follow-up by CEA justified?
Yamamoto S; Akasu T; Fujita S; Moriya Y
Hepatogastroenterology; 2005; 52(62):444-9. PubMed ID: 15816454
[TBL] [Abstract][Full Text] [Related]
4. [After care in colorectal cancer].
Brunner H
Wien Med Wochenschr; 1988 Jun; 138(11-12):261-3. PubMed ID: 3176505
[TBL] [Abstract][Full Text] [Related]
5. [Validity and limitations of the CEA test in the treatment of colorectal carcinoma].
Vuolo G; De Stefano A; Bovenga S; Roviello F; Piccolomini A; Bruttini S; Pinto E; Lorenzoni P; Ceccarini C
G Chir; 1989 Jun; 10(6):339-42. PubMed ID: 2518432
[TBL] [Abstract][Full Text] [Related]
6. Detection of carcinoembryonic antigen messenger RNA-expressing cells in peripheral blood 7 days after curative surgery is a novel prognostic factor in colorectal cancer.
Sadahiro S; Suzuki T; Maeda Y; Yurimoto S; Yasuda S; Makuuchi H; Kamijo A; Murayama C
Ann Surg Oncol; 2007 Mar; 14(3):1092-8. PubMed ID: 17200912
[TBL] [Abstract][Full Text] [Related]
7. Carcinoembryonic antigen in patients with gastric carcinoma.
Janssen CW; Orjasaeter H
Eur J Surg Oncol; 1986 Mar; 12(1):19-23. PubMed ID: 3956751
[TBL] [Abstract][Full Text] [Related]
8. [Value of blood assay of tumor markers for detecting recurrence of colorectal cancer].
Pélissier E; Bosset JF; Meneveau N
Bull Cancer; 1994 Dec; 81(12):1050-6. PubMed ID: 7742592
[TBL] [Abstract][Full Text] [Related]
9. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.
Takagawa R; Fujii S; Ohta M; Nagano Y; Kunisaki C; Yamagishi S; Osada S; Ichikawa Y; Shimada H
Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401
[TBL] [Abstract][Full Text] [Related]
10. [CEA determination in the follow-up of colorectal cancers].
Lauterbach M; Dehne A; Hesse V; Höfig G
Zentralbl Chir; 1987; 112(15):968-74. PubMed ID: 3673304
[TBL] [Abstract][Full Text] [Related]
11. Slope analysis of CA19-9 and CEA for predicting recurrence in colorectal cancer patients.
Nakayama T; Watanabe M; Teramoto T; Kitajima M
Anticancer Res; 1997; 17(2B):1379-82. PubMed ID: 9137502
[TBL] [Abstract][Full Text] [Related]
12. [Significance of 2d look operations in colorectal cancers].
Pelikán A
Zentralbl Chir; 1986; 111(18):1109-12. PubMed ID: 3788330
[TBL] [Abstract][Full Text] [Related]
13. Serum p53 antibody as tumor marker for follow-up of colorectal cancer after curative resection.
Tang R; Yeh CY; Wang JY; Changchien CR; Chen JS; Hsieh LL
Ann Surg Oncol; 2009 Sep; 16(9):2516-23. PubMed ID: 19565285
[TBL] [Abstract][Full Text] [Related]
14. [Value of CEA in the early diagnosis of colorectal cancer recurrence in the light of second-look results].
Colombo PL; Lovotti D; Franco F; Coronelli M; Bonacasa R
Minerva Med; 1986 Mar; 77(13):495-8. PubMed ID: 3703341
[No Abstract] [Full Text] [Related]
15. Negative serum carcinoembryonic antigen has insufficient accuracy for excluding recurrence from patients with Dukes C colorectal cancer: analysis with likelihood ratio and posttest probability in a follow-up study.
Hara M; Kanemitsu Y; Hirai T; Komori K; Kato T
Dis Colon Rectum; 2008 Nov; 51(11):1675-80. PubMed ID: 18633674
[TBL] [Abstract][Full Text] [Related]
16. [Significance of carcinoembryonic antigen in the follow up of colorectal cancer].
Sanz Rubiales A; García Alvarez G
Med Clin (Barc); 1998 Feb; 110(7):277-8. PubMed ID: 9562956
[No Abstract] [Full Text] [Related]
17. Carcinoembryonic antigen for the detection of recurrent disease following curative resection of colorectal cancer.
Wichmann MW; Lau-Werner U; Müller C; Hornung HM; Stieber P; Schildberg FW;
Anticancer Res; 2000; 20(6D):4953-5. PubMed ID: 11326645
[TBL] [Abstract][Full Text] [Related]
18. Carcinoembryonic antigen and patterns of recurrence after curative resection of the colorectal cancer.
Park JY; Lee KH
Hepatogastroenterology; 2007; 54(79):1966-9. PubMed ID: 18251140
[TBL] [Abstract][Full Text] [Related]
19. Intensified follow-up in colorectal cancer patients using frequent Carcino-Embryonic Antigen (CEA) measurements and CEA-triggered imaging: Results of the randomized "CEAwatch" trial.
Verberne CJ; Zhan Z; van den Heuvel E; Grossmann I; Doornbos PM; Havenga K; Manusama E; Klaase J; van der Mijle HC; Lamme B; Bosscha K; Baas P; van Ooijen B; Nieuwenhuijzen G; Marinelli A; van der Zaag E; Wasowicz D; de Bock GH; Wiggers T
Eur J Surg Oncol; 2015 Sep; 41(9):1188-96. PubMed ID: 26184850
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of predictive biomarkers for therapeutical strategies in colorectal cancer.
Gasser M; Gerstlauer C; Grimm M; Bueter M; Lebedeva T; Lutz J; Maeder U; Ribas C; Ribas C; Nichiporuk E; Thalheimer A; Heemann U; Thiede A; Meyer D; Waaga-Gasser AM
Ann Surg Oncol; 2007 Apr; 14(4):1272-84. PubMed ID: 17211733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
